Which of the following anti-lipidemic drugs are the most potent antilipidemic agents, and have proven to lower the risk of Myocardial Infarction?

Urecholine is the brand name of bethanechol, a drug that belongs to the class of cholinergics, genitourinary.

It is used to treat urinary retention by stimulating the bladder to contract and empty.Urecholine can be taken orally or by injection.

Choice A is wrong because adrenergic drugs are those that activate the sympathetic nervous system, which is responsible for the fight-or-flight response.Adrenergic drugs can cause relaxation of the bladder and urinary retention, not contraction and emptying.

Choice B is wrong because anticholinergic drugs are those that block the action of acetylcholine, a neurotransmitter that mediates the parasympathetic nervous system, which is responsible for the rest-and-digest response.Anticholinergic drugs can also cause relaxation of the bladder and urinary retention, not contraction and emptying.

Choice D is wrong because adrenergic blockers are those that inhibit the action of adrenergic receptors, which are activated by adrenergic drugs or by the natural neurotransmitters norepinephrine and epinephrine.Adrenergic blockers can have various effects on the bladder depending on the type and location of the receptors they block, but they are not used to treat urinary retention.

Nitroglycerin is a medication that dilates the blood vessels and improves blood flow to the heart. It is used to treat angina, a condition that causes chest pain due to reduced oxygen supply to the heart. However, nitroglycerin can lose its effectiveness over time if it is used continuously. This is called tolerance, and it means that the patient will need higher doses of the medication to achieve the same relief. To avoid tolerance, patients who use transdermal nitroglycerin patches are instructed to remove the patch at bedtime and apply a new one in the morning. This creates a nitrate-free interval of about 8 to 12 hours, which allows the body to restore its sensitivity to nitroglycerin.

Choice A is wrong because an allergic response is not a common side effect of nitroglycerin. Some patients may experience skin irritation or rash at the site of application, but this is usually mild and does not require discontinuation of the medication.

Choice C is wrong because overdosage is unlikely with transdermal nitroglycerin patches. The patches deliver a controlled amount of nitroglycerin through the skin over a period of time. The risk of overdosage is higher with other forms of nitroglycerin, such as tablets or sprays, which are taken as needed for acute angina attacks.

Choice D is wrong because forgetting to remove the patch in the morning is not a serious problem. The patch will continue to deliver nitroglycerin until it is removed, but it will not cause harm to the patient. However, it may reduce the effectiveness of the next patch if there is no nitrate-free interval between them.